Cargando…
Management of COVID-19 in Patients with Pulmonary Arterial Hypertension
In this review, we discuss the evidence regarding the course and management of COVID-19 in patients with pulmonary arterial hypertension (PAH), the challenges in PAH management during the pandemic and, lastly, the long-term complications of COVID-19 in relation to pulmonary vascular disease. The inh...
Autores principales: | Farmakis, Ioannis T., Giannakoulas, George |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9364740/ https://www.ncbi.nlm.nih.gov/pubmed/36435565 http://dx.doi.org/10.1016/j.hfc.2022.07.003 |
Ejemplares similares
-
Haemodynamic effects of initial combination therapy in pulmonary arterial hypertension: a systematic review and meta-analysis
por: Farmakis, Ioannis T., et al.
Publicado: (2022) -
Echocardiography in Pulmonary Arterial Hypertension: Is It Time to Reconsider Its Prognostic Utility?
por: Farmakis, Ioannis T., et al.
Publicado: (2021) -
Incidence and outcomes of COVID-19 in patients with pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension: Data from the Hellenic pulmOnary hyPertension rEgistry (HOPE)
por: Farmakis, Ioannis T., et al.
Publicado: (2022) -
Epidemiology and initial management of pulmonary arterial hypertension: real-world data from the Hellenic pulmOnary hyPertension rEgistry (HOPE)
por: Arvanitaki, Alexandra, et al.
Publicado: (2019) -
Social determinants of health in pulmonary embolism management and outcome in hospitals: Insights from the United States nationwide inpatient sample
por: Farmakis, Ioannis T., et al.
Publicado: (2023)